|Bid||59.47 x 900|
|Ask||80.00 x 800|
|Day's Range||59.25 - 61.29|
|52 Week Range||56.58 - 72.81|
|Beta (3Y Monthly)||0.77|
|PE Ratio (TTM)||18.85|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Henry Schein (HSIC) delivered earnings and revenue surprises of 1.20% and -1.26%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Investing.com - Henry Schein reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that fell short of forecasts.
Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
GW Pharmaceuticals (GWPH) is witnessing a solid new patient recruitment for Epidolex and a huge number of physicians are recommending the same in their prescriptions.
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Better-than-expected performance at Technology & Equipment and growth in emerging markets are likely to aid DENTSPLY SIRONA (XRAY) in Q2 earnings.
Better-than-expected performance at Pharmaceutical Distribution and higher revenues are likely to aid AmerisourceBergen (ABC) in Q3 earnings.
Does the July share price for Henry Schein, Inc. (NASDAQ:HSIC) reflect what it's really worth? Today, we will estimate...
Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Henry Schein Inc NASDAQ/NGS:HSICView full report here! Summary * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NegativeShort interest is moderately high for HSIC with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. The $4.69 billion in inflows that ETFs holding HSIC received over the last one-month is a decline from earlier in the period and among the weakest of the past year. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Today we'll evaluate Henry Schein, Inc. (NASDAQ:HSIC) to determine whether it could have potential as an investment...
Looking at Henry Schein, Inc.'s (NASDAQ:HSIC) earnings update in March 2019, analyst forecasts appear to be...